<?xml version="1.0" encoding="UTF-8"?>
<p id="par0110">The plasma total bilirubin of experimental rats administered AESG was not significantly different (
 <italic>P &lt; 0.05</italic>) compared to the plasma total bilirubin of the control after 30 days (
 <xref rid="fig0030" ref-type="fig">Fig. 6</xref>). Plasma conjugated bilirubin was significantly elevated (
 <italic>P &lt; 0.05</italic>) in experimental rats administered AESG 500 mg/kg; whereas significant reduction (
 <italic>P &lt; 0.05</italic>) was observed in test rat administered AESG 1000 and 2000 mg/kg respectively compared to the plasma conjugated bilirubin of the control (
 <xref rid="fig0030" ref-type="fig">Fig. 6</xref>) after 30 days. There was significant elevation (
 <italic>P &lt; 0.05</italic>) in plasma unconjugated bilirubin levels of experimental rats administered AESG 1000 and 2000 mg/kg respectively; while experimental rats administered AESG 500 mg/kg was not significantly different (
 <italic>P &lt; 0.05</italic>) compared to the plasma unconjugated bilirubin of the control (
 <xref rid="fig0030" ref-type="fig">Fig. 6</xref>) after 30 days.
</p>
